The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
1548683 |
7 |
Antiestrogens. 3. Estrogen receptor affinities and antiproliferative effects in MCF-7 cells of phenolic analogues of trioxifene, [3,4-dihydro-2-(4- methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]- phenyl]methanone. |
Eli Lilly |
2738897 |
24 |
17-Desoxy estrogen analogues. |
Sri International |
11738564 |
9 |
Synthesis and biological evaluation of novel thio-substituted chromanes as high-affinity partial agonists for the estrogen receptor. |
Novo Nordisk |
10714509 |
4 |
Synthesis and pharmacology of a novel pyrrolo[2,1,5-cd] indolizine (NNC 45-0095), a high affinity non-steroidal agonist for the estrogen receptor. |
Novo Nordisk |
11055361 |
17 |
Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives. |
Novo Nordisk |
10328300 |
4 |
Synthesis and biological activity of trans-2,3-dihydroraloxifene. |
Eli Lilly |
10098655 |
9 |
Novel nonsteroidal selective estrogen receptor modulators. Carbon and heteroatom replacement of oxygen in the ethoxypiperidine region of raloxifene. |
Eli Lilly |
10476873 |
2 |
Synthesis and estrogen receptor binding affinity of a porphyrin-estradiol conjugate for targeted photodynamic therapy of cancer. |
Boston University School of Medicine |
12781198 |
108 |
Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore. |
Ligand Pharmaceuticals |
12781197 |
59 |
Synthesis and biological activity of 5-methylidene 1,2-dihydrochromeno[3,4-f]quinoline derivatives as progesterone receptor modulators. |
Ligand Pharmaceuticals |
10743938 |
103 |
Nonsteroidal progesterone receptor antagonists based on 6-thiophenehydroquinolines. |
Ligand Pharmaceuticals |
15109649 |
44 |
Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs. |
Merck Research Laboratories |
12749898 |
11 |
A novel estrogen receptor ligand template. |
Bayer |
12749895 |
37 |
Tetrahydroquinoline-based selective estrogen receptor modulators (SERMs). |
Eli Lilly |
10230628 |
95 |
Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one. |
Ligand Pharmaceuticals |
9871534 |
95 |
New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone. |
Ligand Pharmaceuticals |
15771467 |
34 |
Discovery of novel quinoline-based estrogen receptor ligands using peptide interaction profiling. |
Glaxosmithkline Research & Development |
15509159 |
16 |
Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor. |
Trinity College Dublin |
15380208 |
39 |
Benzothiophene and naphthalene derived constrained SERMs. |
Eli Lilly |
15324884 |
31 |
Synthesis and biological evaluation of stilbene-based pure estrogen antagonists. |
Universit£T Regensburg |
14971899 |
9 |
Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells. |
University of Colorado |
14736241 |
15 |
Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding. |
University of Illinois |
12672249 |
7 |
Antiestrogenically active 1,1,2-tris(4-hydroxyphenyl)alkenes without basic side chain: synthesis and biological activity. |
Free University of Berlin |
12954049 |
2 |
Discovery and preclinical characterization of (+)-3-[4-(1- piperidinoethoxy)phenyl]spiro[indene- 1,1'-indane]-5,5'-diol hydrochloride: a promising nonsteroidal estrogen receptor agonist for hot flush. |
Dainippon Pharmaceutical |
11297454 |
5 |
Flexible estrogen receptor modulators: design, synthesis, and antagonistic effects in human MCF-7 breast cancer cells. |
Trinity College |
11495597 |
1 |
Photochemical synthesis of N-arylbenzophenanthridine selective estrogen receptor modulators (serms). |
Eli Lilly |
9089332 |
24 |
Cytotoxicity and antiestrogenicity of a novel series of basic diphenylethylenes. |
Universit£ |
9371241 |
11 |
Synthesis and biological evaluation of 4-(hydroxyalkyl)estradiols and related compounds. |
Ohio State University |
9003514 |
73 |
Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene. |
Eli Lilly |
9216841 |
8 |
Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties. |
Inserm Unit� |
9216828 |
42 |
(S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen. |
Le Centre Hospitalier Universitaire De Qu£Bec |
8627615 |
16 |
2-(Hydroxyalkyl)estradiols: synthesis and biological evaluation. |
Ohio State University |
8784443 |
17 |
Novel 5-aminoflavone derivatives as specific antitumor agents in breast cancer. |
Kyowa Hakko Kogyo |
28426931 |
59 |
Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ER? and ER? Activity. |
Trinity College |
2909731 |
6 |
Phenolic metabolites of clomiphene: [(E,Z)-2-[4-(1,2-diphenyl-2-chlorovinyl)phenoxy]ethyl]diethylamine. Preparation, electrophilicity, and effects in MCF 7 breast cancer cells. |
University of Georgia |